Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals

Nephrology Dialysis Transplantation

Volumn 27, Issue 4, 2012, Pages 1410-1415

  Johns, Barry R ^a   Pao, Alan C ^a   Kim, Sun H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chronic kidney disease; estimated glomerular filtration rate; insulin resistance; metabolic syndrome

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK FACTOR;

ADULT; CALIFORNIA; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN RESISTANCE; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 84859348886     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr498     Document Type: Article

References (38)

1. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167-174
2. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134-2140 (Pubitemid 41716445)
3. Chen J, Gu D, Chen CS et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant 2007; 22: 1100-1106 (Pubitemid 46523424)
4. Luk AO, So WY, Ma RC et al. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care 2008; 31: 2357-2361
5. Chen J, Muntner P, Hamm LL et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003; 14: 469-477 (Pubitemid 36150872)
6. Landau M, Kurella-Tamura M, Shlipak MG et al. Correlates of insulin resistance in older individuals with and without kidney disease. Nephrol Dial Transplant 2011; Epub ahead of print
7. Kim SH, Abbasi F, Reaven GM. Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care 2004; 27: 1998-2002 (Pubitemid 38989245)
8. Yeni-Komshian H, Carantoni M, Abbasi F et al. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 2000; 23: 171-175 (Pubitemid 30071019)
9. DeFronzo RA, Tobin JD, Rowe JW et al. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 1978; 62: 425-435 (Pubitemid 8393313)
10. Kobayashi S, Maesato K, Moriya H et al. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 2005; 45: 275-280 (Pubitemid 40431052)
11. Nerpin E, Riserus U, Ingelsson E et al. Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort. Diabetes Care 2008; 31: 1550-1555
12. U.S. Department of Health and Human Services PHS. NHANES III Anthropometric Procedures Video Washington, DC. U.S. Government Printing Office.
13. U.S. Department of Health and Human Services PHS. NHANES III Anthropometric Procedures Video.Washington, DC: U.S. Government Printing Office, 1996 Rule AD, Larson TS, Bergstralh EJ et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141: 929-937
14. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
15. Pei D, Jones CN, Bhargava R et al. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 1994; 37: 843-845 (Pubitemid 24247858)
16. Greenfield MS, Doberne L, Kraemer F et al. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 1981; 30: 387-392 (Pubitemid 11022826)
17. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholestrol in Adults (Adult treatment panel III). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). JAMA 2001; 285: 2486-2497
18. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American heart Association/National heart, Lung, and blood Institute Scientific statement. Circulation 2005; 112: 2735-2752 (Pubitemid 41532612)
19. Maschio G, Alberti D, Janin G et al. Effect of the angiotensinconverting- enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive renal Insufficiency Study Group. N Engl J Med 1996; 334: 939-945 (Pubitemid 26114159)
20. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 1997; 349: 1857-1863
21. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869
22. Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. New Engl J Med 2001; 345: 851-860
23. Tonelli M, Isles C, Craven T et al. Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease. Circulation 2005; 112: 171-178 (Pubitemid 40982298)
24. Shepherd J, Kastelein JJ, Bittner V et al. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The treating to New Targets (TNT) study. Clin J Am Soc Nephrol 2007; 2: 1131-1139
25. Finucane FM, Luan J, Wareham NJ et al. Correlation of the leptin: adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 2009; 52: 2345-2349
26. Buckalew VM Jr., Berg RL, Wang SR et al. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis 1996; 28: 811-821 (Pubitemid 26412076)
27. Ejerblad E, Fored CM, Lindblad P et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006; 17: 1695-1702 (Pubitemid 43794672)
28. Wang Y, Chen X, Song Y et al. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 2008; 73: 19-33 (Pubitemid 350273639)
29. Fox CS, Larson MG, Leip EP et al. Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care 2005; 28: 2436-2440 (Pubitemid 41384290)
30. Hunsicker LG, Adler S, Caggiula A et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997; 51: 1908-1919 (Pubitemid 27252762)
31. Muntner P, Coresh J, Smith JC et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000; 58: 293-301 (Pubitemid 30429874)
32. de Boer IH, Katz R, Fried LF et al. Obesity and change in estimated GFR among older adults. Am J Kidney Dis 2009; 54: 1043-1051
33. Ferrannini E, Balkau B, Coppack SW et al. Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 2007; 92: 2885-2892 (Pubitemid 47236346)
34. Meigs JB, D'Agostino RB Sr., Wilson PW et al. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997; 46(10):1594-1600 (Pubitemid 27411235)
35. Lima NK, Abbasi F, Lamendola C et al. Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension. Am J Hypertens 2009; 22: 106-111
36. Kahn R, Buse J, Ferrannini E et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American diabetes association and the European association for the study of diabetes. Diabetes Care 2005; 28: 2289-2304 (Pubitemid 41242486)
37. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem 2005; 51: 931-938 (Pubitemid 40740871)
38. Grundy SM. Does the metabolic syndrome exist? Diabetes Care 2006; 29: 1689-1692;discussion 1693 (Pubitemid 44127605)